The CD64 cellular binding kit is designed for monitoring the binding of the IgG Fc region to the human CD64 receptor on live cells.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Protein Quantification |
Sample Volume | 5 µL |
The CD64 cellular binding kit is designed for monitoring the binding of the IgG Fc region to the human CD64 receptor on live cells.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
The CD64 (FcgRI) cellular binding assay is a simple and robust test to monitor binding of the IgG Fc region to the human CD64 receptor in live cells and to select the most potent antibody for use in protective functions of the immune system. This assay, based on our innovative Tag-lite technology, can easily be automated to create a high-throughput solution for predicting phagocytosis and immune cell activation.
Application |
Protein Quantification
|
---|---|
Brand |
HTRF
|
Detection Modality |
HTRF
|
Product Group |
Kit
|
Sample Volume |
5 µL
|
Shipping Conditions |
Shipped in Dry Ice
|
Target Class |
Biologics
|
Technology |
TR-FRET
|
Therapeutic Area |
Cardiovascular
Infectious Diseases
Metabolism/Diabetes
NASH/Fibrosis
Neuroscience
Rare Diseases
|
Unit Size |
100 Assay Points
|
The CD64 receptor cellular binding assay is a competitive assay involving HEK293 cells expressing a specific CD64 variant conjugated to Lumi4-terbium Cryptate, and human IgG1 labelled with d2. The unlabeled antibody or Fc tagged drug competes with the d2 labelled IgG1 for binding to the receptor, resulting in a decrease of FRET signal.
The CD64 receptor cellular binding assays (FcgI) present only 1 incubation step after reagents distribution. Lumi4-terbium Cryptate pre-labelled cells are dispensed, followed by the addition of IgG1 labelled with d2 and the sample. After 2h incubation at RT, the signal can be read.
Are you looking for resources, click on the resource type to explore further.
Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...
This guide provides you an overview of HTRF applications in several therapeutic areas.
We are here to answer your questions.